Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic
View
Johan de Munter, EBMT 2023: Highlights from the Nurses Group Keynote Lecture
View
New horizons in R/R follicular lymphoma: Focus on risk stratification and managing the practicalities of CAR T-cell therapy
View
Phase 3 BASIS trial – efficacy and safety of marstacimab in severe haemophilia A or B without inhibitors: Davide Matino, ASH 2023
View
Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice
View
Robin Foa, EBMT23: Should we transplant all patients with Philadelphia positive ALL?
View
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
View
Revumenib in relapsed/refractory KMT2Ar acute leukaemia – AUGMENT-101 phase 2 study: Ibrahim Aldoss, ASH 2023
View
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
View
Renoir phase 3 study – rituximab and lenalidomide versus rituximab for elderly patients with r/r follicular lymphoma: Umberto Vitolo, ASH 2023
View